Join
Live feed
·
SECFilingvia Quantisnow
Entero Therapeutics Inc. logo

Entero Therapeutics Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation, Changes in Control of Registrant, Leadership Update, Financial Statements and Exhibits

ByQuantisnow·Wall Street's wire, on your screen.
ENTO· Entero Therapeutics Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track ENTO (Entero Therapeutics Inc.) and more on Quantisnow.

Entero Therapeutics Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation, Changes in Control of Registrant, Leadership Update, Financial Statements and Exhibits | Quantisnow